Chinese pharmaceutical start-up CARsgen Therapeutics has completed a US$30 million series B round of financing led by KTB Ventures and Jolly Innovation Ventures, according to an announcement.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access Over 11,000 stories and data posts over the past 8 years!Register Now
Already have an account or paid subscription?